NIH study identifies experimental opioid with strong pain relief and lower addiction risk
2026-04-09
·
via TechSpot
The study focuses on DFNZ, a molecule derived from a class of synthetic opioids first explored in the mid-20th century b
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。
